Nov 12, 2020
C-suite leaders in pharmaceutical companies increasingly view Real World Evidence (RWE) as strategically important. RWE enables R&D organisations to prioritise their pipeline investments more effectively, better understand underlying causes of disease and identify opportunities for indication expansion and...